Gastric mucosa-associated lymphoid tissue lymphoma

Area of Science:

• Gastroenterology
• Oncology
• Immunology

Background:

• Helicobacter pylori infection is strongly linked to gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
• Infection triggers chronic gastritis and the formation of lymphoid follicles in the stomach, which can develop into MALT lymphoma.
• MALT lymphoma arises from clonal expansion of B cells within these lymphoid follicles.

Purpose of the Study:

• To highlight the diagnostic challenges and essential treatment strategies for gastric MALT lymphoma.
• To emphasize the role of H. pylori eradication in early-stage disease.
• To outline the importance of comprehensive staging and long-term follow-up.

Main Methods:

• Review of clinical presentation, endoscopic findings, and diagnostic modalities including endoscopic ultrasound.
• Discussion of treatment approaches based on disease stage: H. pylori eradication for early stages, and surgery, radiation, or chemotherapy for advanced stages.
• Emphasis on rigorous follow-up protocols including biopsies and endoscopic ultrasound post-treatment.

Main Results:

• Early diagnosis of MALT lymphoma is challenging due to vague symptoms and varied endoscopic appearances.
• H. pylori eradication is effective for MALT lymphomas confined to the mucosa or submucosa.
• Advanced stage MALT lymphomas necessitate multimodal treatment strategies.

Conclusions:

• Gastric MALT lymphoma is closely associated with H. pylori infection, with early-stage disease often treatable by eradication.
• Accurate staging using endoscopic ultrasound is crucial for determining appropriate management.
• Indefinite, rigorous follow-up is essential due to the potential for late recurrence of MALT lymphoma.